The current ANRO market cap is 334.12M. The company's latest EPS is USD -1.3550 and P/E is -9.19.
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 0 | 0 |
Operating Income | -29.19M | -37.81M |
Net Income | -27.71M | -36.31M |
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 50.85M | 86.63M |
Total Liabilities | 17.03M | 16.82M |
Total Equity | -38.41M | -71.67M |
Market Cap | 334.12M |
Price to Earnings Ratio | -9.19 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.04 |
Price to Book Ratio | 4.78 |
Dividend Yield | - |
Shares Outstanding | 26.79M |
Average Volume (1 week) | 87.87k |
Average Volume (1 Month) | 86.4k |
52 Week Change | -43.32% |
52 Week High | 24.00 |
52 Week Low | 12.17 |
Spread (Intraday) | 5.08 (31.75%) |
Company Name | Alto Neuroscience Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.altoneuroscience.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.